20
Lupin Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Olmesartan medoxomil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2014-370 - Rev 01
This Chemical Type CEP, issued on February 18, 2020, remains in force until February 04, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2600 associated with this CEP further emphasizes